A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Seraxis
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult 18 to 65 years with a clinical history of T1D
Diagnosis of T1D at \<40 years of age
insulin dependence for ≥5 years at pre-screening
Recurrent severe hypoglycemia
Willingness to use continuous glucose monitoring
You may not be if
Use of anti-diabetic agent other than insulin(s) or insulin analog(s) within 3 months of Screening
Weight loss medication(s) within 3 months of Screening
Clareo Health | A Study of the Safety and Efficacy of Pancreatic Endocrine Cell Clusters Implanted Into the Omentum of Type 1 Diabetes Patients With Severe Hypoglycemia
